Herein, we report a GHz acoustofluidic-based implantable drug delivery system (GADDS) that leverages nanochannel-based molecular diffusion and acoustic streaming effect-based release modulation for controllable drug delivery.
No takes yet. Share an insight, caveat, or question.
You et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: